PR Newswire - Yingli Pharma Announces Successful End-of-Phase 2 ...
SAN FRANCISCO, April 1, 2025 /PRNewswire/ -- Shanghai Yingli Pharmaceutical Co., Ltd. (Yingli Pharma), a clinical stage biotechnology company developing oral small molecule drugs for cancer, metabolic...
Read More

ภาษาไทย
English